The examination of the way of building a framework that research subjects can recognize the social significance of clinical trials for regenerative medicine

Katsui K.; Takimoto Y.; Nakazawa E.; Akabayashi A.

首页> 外文期刊>Human gene therapy >The examination of the way of building a framework that research subjects can recognize the social significance of clinical trials for regenerative medicine

【24h】

The examination of the way of building a framework that research subjects can recognize the social significance of clinical trials for regenerative medicine

机译：对研究对象可以识别再生医学临床试验的社会意义的构架方法的检验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Human gene therapy》 |2016年第11期|共1页
作者
Katsui K.; Takimoto Y.; Nakazawa E.; Akabayashi A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. The examination of the way of building a framework that research subjects can recognize the social significance of clinical trials for regenerative medicine [J] . Katsui K., Takimoto Y., Nakazawa E., Human gene therapy . 2016,第11期

机译：对研究对象可以识别再生医学临床试验的社会意义的构架方法的检验
2. Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine [J] . Grigorian-Shamagian Lilian, Sanz-Ruiz Ricardo, Climent Andreu, Cardiovascular Research . 2021,第6期

机译：洞察治疗产品，临床前研究模型和心脏再生和修复药物的临床试验：我们现在在哪里以及前方的方式。心血管再生和检测医学中的ESC工作组现行意见论文
3. Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients [J] . Teruo Okano Regenerative Therapy . 2015,第6期

机译：通过医学和工程学融合进行再生治疗：诱导性多能干细胞和细胞片技术的首次人类临床试验：患者再生医学研讨会报告
4. AN INTEGRATED FRAMEWORK FOR REPORTING CLINICALLY RELEVANT BIOMARKERS FROM PAIRED TUMOR/NORMAL GENOMIC AND TRANSCRIPTOMIC SEQUENCING DATA IN SUPPORT OF CLINICAL TRIALS IN PERSONALIZED MEDICINE [C] . SARA NASSER, AHMET A. KURDOLGU, TYLER IZATT, Pacific Symposium on Biocomputing . 2015

机译：一种综合框架，用于报告来自配对肿瘤/正常基因组和转录组序列测序数据的临床相关的生物标志物，以支持个性化医学中的临床试验
5. Creating and testing a theoretical framework for evaluating telemedicine technology acceptance in a clinical trial involving consultations between neonatologists and pediatric surgeons. [D] . Motta, Camille A. 1998

机译：在涉及新生儿科医生和儿科医生的会诊的临床试验中，创建并测试用于评估远程医疗技术接受度的理论框架。
6. Are potentially clinically meaningful benefits misinterpreted in cardiovascular randomized trials? A systematic examination of statistical significance clinical significance and authors’ conclusions [O] . G. Michael Allan, Caitlin R. Finley, James McCormack, 2017

机译：在心血管随机试验中是否会误解具有潜在临床意义的益处？对统计意义临床意义和作者结论的系统检查
7. Are potentially clinically meaningful benefits misinterpreted in cardiovascular randomized trials? A systematic examination of statistical significance, clinical significance, and authors’ conclusions [O] . G. Michael Allan, Caitlin R. Finley, James McCormack, 2017

机译：在心血管随机试验中是否会误解具有潜在临床意义的益处？对统计意义，临床意义和作者结论的系统检查
8. Armed Forces Institute of Regenerative Medicine: Clinical Trials [R] . Irgens, T. 2011

机译：武装部队综合医学研究所：临床试验

The examination of the way of building a framework that research subjects can recognize the social significance of clinical trials for regenerative medicine

著录项

相似文献

相关主题

期刊订阅